Archive

Rebel Category: REBEL EM

Race Multiplier in the eGFR Equation: What’s the impact for African-Americans?

Background: Race is a sociological construct that affects how clinicians deliver health care to various racial/ethnic groups.  This in turn affects clinical outcomes.  Thus, African Americans with chronic kidney disease have worse outcomes with respect to hypertension control, timely nephrology ...

Read More
Ethical and LegalRenal and Genitourinary

RESCUE-Japan LIMIT Trial

Background: The publication of the MR CLEAN trial in January 2015 changed the face of ischemic stroke care. This was the first study demonstrating a benefit to endovascular treatment of a specific subset of ischemic stroke patients: those with a ...

Read More
Neurology

Using the Word “Quiet“ in the ED

Background: For those who believe in superstition, the superstitious belief that saying the word “quiet” while working in the ED will result in a calamitous surge of patients is a real concern. We reviewed a study from 2019 performed in ...

Read More

SSRIs and COVID-19

Background: The effects of the COVID-19 pandemic have been devastating. Given the novelty of the virus, only a few effective treatments have emerged to decrease mortality from SARS-CoV-2 infection. The morbidity and mortality of SARS-CoV-2 is thought to be due ...

Read More
Infectious Disease

The INSPIRATION Trial: Intermediate Dose Anticoagulation in Critically Ill Patients with COVID-19

Background: COVID-19 infection increases the risk of thrombosis due to multiple factors.(Rico-Mesa, 2020). Over the last 2 years, researchers have published 12 RCTs investigating various anticoagulation strategies among patients diagnosed with COVID-19 in multiple clinical settings. To date, only a multiplatform ...

Read More
CardiovascularHematology and OncologyInfectious DiseaseThoracic and Respiratory
Showing Slide 1 of 6

Sponsored